ESC Professional Premium Access

Making best use of the new drugs: ARNI and SGLT2 inhibitors across the spectrum of heart failure

Event: ESC Congress 2022
Topic: Cardiovascular Pharmacotherapy
Session type: Practical Seminar
Date: 26 August 2022
Time: 14:00 - 15:15

Congress Session

Become an ESC Professional member to access this resource

Become a member

Already a member? Sign in

4 presentations in this session

The spectrum of heart failure: current concepts in defining systolic and diastolic cardiac dysfunction.

Speaker: Professor C. Ceconi (Desenzano Del Garda, IT)
Thumbnail

ARNI: evidence across the spectrum of heart failure.

Speaker: Doctor M. Packer (Dallas, US)
Thumbnail

SGLT2 inhibitors: evidence across the spectrum of heart failure.

Speaker: Professor S. Anker (Berlin, DE)
Thumbnail

Putting it all together: ARNI, SGLT2 inhibitors and other drugs across the spectrum of heart failure.

Speaker: Doctor E. O'Meara (Montreal, CA)
Thumbnail

4 speakers from this session

Professor Claudio Ceconi

Unit of Cardiology, Desenzano Del Garda (Italy)
6 presentations
0 follower

Doctor Milton Packer

Baylor University Medical Center, Dallas (United States of America)
33 presentations
3 followers

Professor Stefan Anker

Charite Universitatsmedizin Berlin, Berlin (Germany)
116 presentations
4 followers

Doctor Eileen O'Meara

Montreal Heart Institute, Montreal (Canada)
2 presentations
0 follower

This platform is supported by

logo Novo Nordisk